Etifoxine itinase-IN-2 Hydrochloride which in May 2013 was

which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD)

and human ether-a go-go-related gene (hERG)

Formula: C21H30N4O6S

Stransky N

Formula: C12H11NOS2

Etifoxine itinase-IN-2 Hydrochloride which in May 2013 wasEtifoxine is a positive allosteric modulator of 122 and 132 subunit containing GABAA receptors. Product information CAS Number: 21715 46 8 Molecular Weight: 300. 78 Formula: C17H17ClN2O Chemical Name: N (6 chloro 4 methyl 4 phenyl 2,4 dihydro 1H 3,1 benzoxazin 2 ylidene)ethan 1 amine Smiles: CCN=C1NC2=CC=C(Cl)C=C2C(C)(O1)C1C=CC=CC=1 InChiKey: IBYCYJFUEJQSMK UHFFFAOYSA N InChi: InChI=1S C17H17ClN2O c1 3 19 16 20 15 10 9 13(18)11 14(15)17(2,21 16)12 7 5